Abstract

Supplements for smoking-related lung diseases are considered as nonfood products and thought to improve health. Multivitamins and antioxidants are the most commonly dietary supplements used by cancer and asthma patients. There are currently no clear regulatory guidelines that include dietary supplements and their effect on lung cancer and asthma patients, particularly in smokers. Several countries have taken steps to overcome challenges in regulating dietary supplements in the marketplace. These challenges include inadequate assurance of safety/efficacy, inaccuracy of product labeling, misleading health claims, and lack of analytical techniques for dietary supplements. There is a need to establish standards and regulation of dietary supplement use in patients with lung cancer and asthma. The aim of this entry is to expand knowledge on dietary supplements use and smoking-related lung diseases (lung cancer and asthma).

Highlights

  • In a recent meta-analysis, currently/formerly smoking men and women had an increased risk of lung cancer, with no significant sex differences observed [14]

  • randomized controlled trials (RCT) have been contradictory regarding the effects of dietary supplements on lung cancer risk and mortality in smokers and nonsmokers [48]

  • Dietary supplement use is popular among adult patients with cancers in many countries, due to the belief that these products are safe and will improve health or prevent cancers

Read more

Summary

Introduction

In a recent meta-analysis, currently/formerly smoking men and women had an increased risk of lung cancer, with no significant sex differences observed [14]. In order to evaluate the safety and effectiveness of dietary supplement use by asthmatic smokers and nonsmokers before, during, and after lung cancer treatment, realistic and reliable studies worldwide are needed. RCTs have been contradictory regarding the effects of dietary supplements on lung cancer risk and mortality in smokers and nonsmokers [48].

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.